Moskovich D, Finkelshtein Y, Alfandari A, Rosemarin A, et al. Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. Oncogene 2021 Sep 23. pii: 10.1038/s41388-021-02020.
PMID: 34556811